Sullivan PF, Geschwind DH (2019). Defining the Genetic, Genomic, Cellular, and Diagnostic Architectures of Psychiatric Disorders. Cell. 177(1):162-183.
Publications
2019
Lee SE, Sias AC, Kosik EL, Flagan TM, Deng J, …Geschwind DH, …Seeley WW (2019). Thalamo-cortical network hyperconnectivity in preclinical progranulin mutation carriers. Neuroimage Clin. 22():101751.
Schork AJ, Won H, Appadurai V, Nudel R, Gandal M, …Geschwind DH, …Werge T (2019). A genome-wide association study of shared risk across psychiatric disorders implicates gene regulation during fetal neurodevelopment. Nat Neurosci. 22(3):353-361.
Sangare M, Toure HB, Toure A, Karembe A, Dolo H, Coulibaly YI, …Geschwind DH (2019). Validation of two parent-reported autism spectrum disorders screening tools M-CHAT-R and SCQ in Bamako, Mali. eNeurologicalSci. 15():100188.
Grove J, Ripke S, Als TD, Mattheisen M, Walters RK, …Geschwind DH, …Børglum AD (2019). Identification of common genetic risk variants for autism spectrum disorder. Nat Genet. 51(3):431-444.
Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, …Geschwind DH, …Genetic and Environmental Risk in AD/Defining Genetic, Polygenic and Environmental Risk for Alzheimer’s Disease Consortium (GERAD/PERADES),. (2019). Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat Genet. 51(3):414-430.
